Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.95M Buy
195,700
+22,273
+13% +$527K 0.02% 318
2026
Q1
$3.79M Sell
173,427
-10,102
-6% -$234K 0.02% 337
2025
Q4
$4.27M Buy
183,529
+2,078
+1% +$50.1K 0.02% 328
2025
Q3
$5.14M Sell
181,451
-12,527
-6% -$333K 0.02% 291
2025
Q2
$4.27M Buy
193,978
+54,134
+39% +$1.18M 0.02% 307
2025
Q1
$3.26M Buy
139,844
+13,519
+11% +$346K 0.02% 331
2024
Q4
$3.63M Buy
126,325
+608
+0.5% +$18.2K 0.02% 315
2024
Q3
$3.73M Buy
125,717
+2,303
+2% +$71.5K 0.02% 310
2024
Q2
$4.16M Buy
+123,414
New +$4.26M 0.02% 281

Other funds holding GNTX

Scotia Capital's GNTX Position: Q2 2026 in Review

Scotia Capital increased its Gentex (GNTX) stake by 13% in Q2 2026, buying an estimated $527K and bringing the position to 195,700 shares worth $4.95M. The position accounts for 0.02% of the portfolio, ranked #318.

Scotia Capital first reported a position in GNTX in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.14M in Q3 2025. 531 funds tracked by Wall St. Rank hold GNTX as of Q2 2026.

  • Scotia Capital held 195,700 shares of Gentex worth $4.95M as of Q2 2026.
  • Scotia Capital bought 22,273 Gentex shares in Q2 2026, an estimated $527K.
  • Gentex made up 0.02% of Scotia Capital's portfolio in Q2 2026, its #318 holding.
  • Scotia Capital first reported a position in Gentex in Q2 2024 and has held it in 9 quarters since.
  • Scotia Capital's Gentex position peaked at $5.14M in Q3 2025.
  • 531 funds tracked by Wall St. Rank held Gentex as of Q2 2026.

Based on Scotia Capital's 13F filing for Q2 2026, filed 11 Aug 2026.